Pharmaceutical Industry Information Portal

HomeNews

News

Rapid growth characterizes production of china’s vaccines

More than 1.4 billion doses of vaccines have been administered in China, and the country has provided over 500 million doses of vaccines overseas to assist in the global fight against the pandemic.

Russia wants to take down barriers for global production, distribution of vaccines

Russia actively fosters localization of its vaccine production abroad, which is based on technology transfer, while agreements were inked with several foreign companies.

Single-dose Sputnik Light vaccine registered in Kazakhstan

Sputnik Light demonstrated 79.4% efficacy according to analyzed data taken from 28 days after the injection was administered. In February 2021, Kazakhstan approved the two-dose Sputnik V vaccine.

WTO issues joint indicative list of critical inputs for COVID-19 vaccines

The WTO Secretariat has published an indicative list compiling information on the critical inputs for the manufacturing, distributing and administering of COVID-19 vaccines.

RDIF and Serum Institute of India to start production of Sputnik vaccine in September

The first batch of Sputnik vaccine is expected to be produced at SII’s facilities in September. The parties intend to produce over 300 million doses of the vaccine in India per year.

R-Pharm and Frontier Biotech will provide Russia with a new drug for the treatment of HIV

Aikening™ is a new fusion inhibitor. It is the first and only long-acting injectable (as IV infusion QW) available as a dual therapy for treatment-experienced patients with HIV-1 replication.
spot_img

Expert Articles

spot_img